Answers are grounded in this paper and cite their sources.
Optimal treatment combinations for a nonlinear objective function are considered while controlling for multiple adverse outcomes. The objective response is modeled using a second-order approximation, while adverse outcomes define the tolerable dosage region. Model parameters are estimated within a Bayesian framework using a Markov chain Monte Carlo method. The resulting constrained optimization problems are solved numerically, and a representative dosage combination is selected using the 5th percentile of the Euclidean distances of the posterior optimal solutions from the origin. Simulation studies consider cases in which the unconstrained maximum lies inside or outside the tolerable region. The method identifies dosage combinations near the true maximum when it is feasible and adjusts the recommendation when adverse-outcome constraints are active. In the two-treatment simulations, the recommended doses satisfied the true adverse-outcome constraints across the scenarios considered, and the numerical optimality verification rate was 100%. Additional simulations examine the effects of response variability and objective function curvature. An illustrative three-treatment example with pairwise interactions further demonstrates the applicability of the approach to higher-dimensional dosage combinations. The results provide a flexible approach for optimizing treatment combinations under nonlinear dosage–response relationships.
No takes yet. Share an insight, caveat, or question.
Boone et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: